Corbel Holdings, Inc.

HaloLaser to acquire the assets of FHJ Scientific, Inc.

Published in Pharma Law Weekly, December 14th, 2004

HaloLaser Biotherapy, LLC, announced the signing of a letter of intent to acquire the assets of FHJ Scientific, Inc., for $1.2 million in stock, to be included in the merger agreement with Corbel Holdings, Inc., (CBLH).

The purchase includes five letters of patent, together with several foreign patents and/or patents pending and other assets of FHJ.

FHJ is a privately held Texas corporation, which was formed in 1985. FHJ has the proprietary SHBAN Solution. In vitro and other testing have, according to the company, demonstrated the capabilities and superiority of SHBAN over known commercial products in applications covering contact dermatitis, dermal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2004-12-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry